Shu Zhao
- Cancer Research top 5%
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 3
- Immunology top 10%
- Aquaculture disease management and microbiota 11
- Invertebrate Immune Response Mechanisms 5
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms 3
- Endocrinology top 10%
- Vibrio bacteria research studies 6
- Insect Science top 5%
-
- Extracellular vesicles in disease 6
-
- Antimicrobial Peptides and Activities 4
- Co-authors
- Jialin ZhengXiaohuan XiaWenhong FangYi WangYinguang ChenXin-Cang LiXiong ZhengQingyuan Zhang
- Cited by
- Cancer ResearchImmunologyNeurology
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Shu Zhao
53 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 115
- Cancer Research 317
- Immunology 317
- Neurology 103
- Endocrinology 60
- Insect Science 139
Countries citing papers authored by Shu Zhao
This map shows the geographic impact of Shu Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Zhao more than expected).
Fields of papers citing papers by Shu Zhao
This network shows the impact of papers produced by Shu Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Zhao. The network helps show where Shu Zhao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shu Zhao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2022 | 69 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 18 | |
| 6 | 2020 | 67 | |
| 7 | 2019 | 17 | |
| 8 | 2019 | 10 | |
| 9 | 2019 | 8 | |
| 10 | 2018 | 32 | |
| 11 | 2017 | 32 | |
| 12 | 2017 | 25 | |
| 13 | 2016 | 11 | |
| 14 | 2016 | 23 | |
| 15 | 2016 | 4 | |
| 16 | 2014 | 85 | |
| 17 | 2014 | 103 | |
| 18 | 2013 | 17 | |
| 19 | 2013 | 4 | |
| 20 | 2013 | 17 |
About Shu Zhao
Shu Zhao is a scholar working on Endocrinology, Immunology and Microbiology, having authored 53 papers that have together received 1.4k indexed citations. Recurring topics across this work include Aquaculture disease management and microbiota (11 papers), Vibrio bacteria research studies (6 papers), Extracellular vesicles in disease (6 papers), Invertebrate Immune Response Mechanisms (5 papers), Antimicrobial Peptides and Activities (4 papers), MicroRNA in disease regulation (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (317 citations), Immunology (317 citations) and Neurology (103 citations). Shu Zhao has collaborated with scholars based in China, United States and France. Frequent co-authors include Jialin Zheng, Xiaohuan Xia, Wenhong Fang, Yi Wang, Yinguang Chen, Xin-Cang Li, Xiong Zheng, Qingyuan Zhang, Xiang Li and Junfang Zhou. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.